Thailand Alzheimers Disease Diagnostics Market Size & Outlook

The alzheimers disease diagnostics market in Thailand is expected to reach a projected revenue of US$ 183.9 million by 2033. A compound annual growth rate of 11.7% is expected of Thailand alzheimers disease diagnostics market from 2026 to 2033.
Revenue, 2025 (US$M)
$76.6
Forecast, 2033 (US$M)
$183.9
CAGR, 2026 - 2033
11.7%
Report Coverage
Thailand

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Thailand alzheimers disease diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Thailand alzheimers disease diagnostics market highlights

  • The Thailand alzheimers disease diagnostics market generated a revenue of USD 76.6 million in 2025 and is expected to reach USD 183.9 million by 2033.
  • The Thailand market is expected to grow at a CAGR of 11.7% from 2026 to 2033.
  • In terms of segment, imaging techniques was the largest revenue generating diagnostic technique in 2025.
  • Biomarkers is the most lucrative diagnostic technique segment registering the fastest growth during the forecast period.


Alzheimers disease diagnostics market data book summary

Market revenue in 2025USD 76.6 million
Market revenue in 2033USD 183.9 million
Growth rate11.7% (CAGR from 2026 to 2033)
Largest segmentImaging techniques
Fastest growing segmentBiomarkers
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationBiomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests
Key market players worldwideQuest Diagnostics Inc, Sysmex Corp, Lantheus Holdings Inc, Siemens Healthineers AG ADR, F. Hoffmann-La Roche Ltd., Quanterix, Fujirebio Diagnostics, C2N Diagnostics


Other key industry trends

  • In terms of revenue, Thailand accounted for 0.8% of the global alzheimers disease diagnostics market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China alzheimers disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 600.2 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Alzheimers Disease Diagnostics Market Companies

Name Profile # Employees HQ Website
Quanterix View profile 251-500 Billerica, Massachusetts, United States, North America http://www.quanterix.com
Fujirebio Diagnostics View profile 5001-10000 Malvern, Pennsylvania, United States, North America http://www.fdi.com/
C2N Diagnostics View profile 11-50 Saint Louis, Missouri, United States, North America https://c2n.com/
F. Hoffmann-La Roche Ltd. View profile - - -
Lantheus Holdings Inc View profile 834 201 Burlington Road, South Building, Bedford, MA, United States, 01730 https://www.lantheus.com
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com

Thailand alzheimers disease diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to alzheimers disease diagnostics market will help companies and investors design strategic landscapes.


Imaging techniques was the largest segment with a revenue share of 44.78% in 2025. Horizon Databook has segmented the Thailand alzheimers disease diagnostics market based on biomarkers, imaging techniques, genetic testing, cognitive assessment tests covering the revenue growth of each sub-segment from 2021 to 2033.


The market in Thailand is anticipated to grow at a significant rate over the forecast period, owing to the innovation in diagnostic tools in detecting dementia. For instance, according to an article published by Chulalongkorn University, in January 2023, there were 700,000 dementia patients in Thailand, with 500,00 of them having Alzheimer's. 

The number of dementia cases will rise if social and individual actions are not taken to slow or prevent dementia. According to Dr. Poosanu, the Emerging Infectious Diseases Health Science Center employs immunological methods rather than lumbar puncture for blood tests. 

Simoa (single molecule array) or LC-MS (mass spectrometry) are used for analysis in order to find phosphorylated Tau in the blood, which may be a sign of latent Alzheimer's disease, and Neurofilament light chan, a test for the loss of brain cells. 

Reasons to subscribe to Thailand alzheimers disease diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Thailand alzheimers disease diagnostics market databook

  • Our clientele includes a mix of alzheimers disease diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Thailand alzheimers disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Thailand alzheimers disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Thailand alzheimers disease diagnostics market size, by diagnostic technique, 2021-2033 (US$M)

Thailand Alzheimers Disease Diagnostics Market Outlook Share, 2025 & 2033 (US$M)

Thailand alzheimers disease diagnostics market size, by diagnostic technique, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online